Establishment and multi drug resistance evolution of ST235 Pseudomonas aeruginosa strains in the intensive care unit of a Colombian hospital

Research in Microbiology

Volumn 165, Issue 10, 2014, Pages 852-856

  Martinez, Elena ^a   Pérez, Javier Escobar ^b   Buelvas, Francisco ^c   Tovar, Catalina ^c   Vanegas, Natasha ^a,b   Stokes, H W ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b UNIVERSIDAD EL BOSQUE   (Colombia)

^c UNIVERSIDAD DEL SINÚ   (Colombia)

Author keywords

Antibiotic resistance; Class 1 integron; Hospital acquired infections; IS26; Pseudomonas aeruginosa ST235

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; TOBRAMYCIN; ANTIINFECTIVE AGENT;

AGAR DIFFUSION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; DNA SEQUENCE; EVOLUTION; GENE CASSETTE; GENE INSERTION SEQUENCE; GENOMIC ISLAND; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INTEGRON; INTENSIVE CARE UNIT; NONHUMAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; TRANSPOSON; CLASSIFICATION; COLOMBIA; CROSS INFECTION; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PSEUDOMONAS INFECTIONS; STATISTICS AND NUMERICAL DATA;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; COLOMBIA; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84918511789     PISSN: 09232508     EISSN: 17697123     Source Type: Journal    
DOI: 10.1016/j.resmic.2014.10.011     Document Type: Article

References (20)

1. Boucher H.W., Talbot G.H., Bradley J.S., Edwards J.E., Gilbert D., Rice L.B., et al. Bad bugs, no drugs: no ESKAPE! an update from the infectious diseases society of America. Clin Infect Dis 2009, 48:1-12.
2. Sardelic S., Bedenic B., Colinon-Dupuich C., Orhanovic S., Bosnjak Z., Plecko V., et al. Infrequent finding of metallo-β-lactamase VIM-2 in carbapenem-resistant Pseudomonas aeruginosa strains from croatia. Antimicrob Agents Chemother 2012, 56:2746-2749.
3. Liakopoulos A., Mavroidi A., Katsifas E., Theodosiou A., Karagouni A., Miriagou V., et al. Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons. BMC Infect Dis 2013, 13:505.
4. Cho H.H., Kwon K.C., Sung J.Y., Koo S.H. Prevalence and genetic analysis of multidrug-resistant Pseudomonas aeruginosa ST235 isolated from a hospital in Korea, 2008-2012. Ann Clin Lab Sci 2013, 43:414-419.
5. Cuzon G., Naas T., Villegas M.-V., Correa A., Quinn J.P., Nordmann P. Wide dissemination of Pseudomonas aeruginosa producing β-lactamase blaKPC-2 gene in Colombia. Antimicrob Agents Chemother 2011, 55:5350-5353.
6. Edelstein M.V., Skleenova E.N., Shevchenko O.V., D'Souza J.W., Tapalski D.V., Azizov I.S., et al. Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study. Lancet Infect Dis 2013, 13:867-876.
7. Carattoli A., Fortini D., Galetti R., Garcia-Fernandez A., Nardi G., Orazo D., et al. Isolation of NDM-1-producing Pseudomonas aeruginosa sequence type ST235 from a stem cell transplant patient in Italy, May 2013. Euro Surveill 2013, 18.
8. Martinez E., Marquez C., Ingold A., Merlino J., Djordjevic S.P., Stokes H.W., et al. Diverse mobilized class 1 integrons are common in the chromosome of pathogenic Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 2012, 56:2169-2172.
9. Curran B., Jonas D., Grundmann H., Pitt T., Dowson C.G. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol 2004, 42:5644-5649.
10. CLSI Performance standards for antimicrobial susceptibility testing 2010, Clinical and Laboratory Standards Institute, Wayne, PA.
11. Marquez C., Labbate M., Raymondo C., Fernandez J., Gestal A.M., Holley M., et al. Urinary tract infections in a South American population: dynamic spread of class 1 integrons and multidrug resistance by homologous and site-specific recombination. J Clin Microbiol 2008, 46:3417-3425.
12. Betteridge T., Partridge S.R., Iredell J.R., Stokes H.W. Genetic context and structural diversity of class 1 integrons from human commensal bacteria in a hospital intensive care unit. Antimicrob Agents Chemother 2011, 55:3939-3943.
13. Martinez E., Pérez J.E., Márquez C., Vilacoba E., Centrón D., Leal A.L., et al. Emerging and existing mechanisms co-operate in generating diverse β-lactam resistance phenotypes in geographically dispersed and genetically disparate Pseudomonas aeruginosa strains. J Glob Antimicrob Resist 2013, 1:135-142.
14. Carattoli A., Bertini A., Villa L., Falbo V., Hopkins K.L., Threfall E.J. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005, 63:219-228.
15. Levesque C., Piche L., Larose C., Roy P.H. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 1995, 39:185-191.
16. Brown H., Stokes H., Hall R. The integrons In0, In2, and In5 are defective transposon derivatives. J Bacteriol 1996, 178:4429-4437.
17. Labbate M., Chowdhury P.R., Stokes H.W. A class 1 integron present in a human commensal has a hybrid transposition module compared to Tn402: evidence of interaction with Mobile DNA from natural environments. J Bacteriol 2008, 190:5318-5327.
18. Cain A.K., Liu X., Djordjevic S.P., Hall R.M. Transposons related to Tn1696 in IncHI2 plasmids in multiply antibiotic resistant Salmonella enterica serovar typhimurium from Australian animals. Microb Drug Resist 2010, 16:197-202.
19. Hocquet D., Llanes C., Thouverez M., Kulasekara H.D., Bertrand X., Plésiat P., et al. Evidence for induction of integron-based antibiotic resistance by the SOS response in a clinical setting. Plos Pathog 2012, 8:e1002778.
20. Livermore D.M. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?. Clin Infect Dis 2002, 34:634-640.